Clinical testing and research laboratories across the globe are working on a war-footing to test and find a vaccine for the novel coronavirus disease (COVID-19). CloudLIMS has already helped multiple labs get up and running in less than a week using FDA approved, preconfigured workflows. Some of the major challenges faced by COVID-19 testing laboratories are as follows:
Biobanks store and provide high-quality COVID-19 specimens and associated metadata to expedite research and clinical trials on COVID-19. Like clinical laboratories, biobanks too face numerous challenges:
A Schematic Representation of a Preconfigured COVID-19 Diagnostic Testing Laboratory Workflow
Receiving Test
Request
Receiving
Specimens
Batch Accessioning
of Specimens
Processing
Specimens
Isolating
Viral RNA
Conducting
RT-PCR Test
Detecting
Amplified cDNA
Importing Results
to a LIMS
Validating Test
Results
Submitting Reports
to FDA & CDC
Sharing
Test Reports
Disposing
Specimens Safely
COVID-19 LIMS Software for Coronavirus Diagnostic Testing Labs, Research Labs and Biobanks
CloudLIMS is a preconfigured, scalable, in the cloud COVID-19 LIMS for COVID-19 research, diagnostic testing laboratories, and biobanks. CloudLIMS is preconfigured with COVID-19 specific tests, such as RT-PCR, serological tests for the detection of IgG/IgM antibodies, Enzyme-linked Immunosorbent Assay (ELISA), neutralization test, and Rapid Diagnostic Test (RDT). Furthermore, it is configured with COVID-19 and other infectious disease workflows and reporting templates for quick reporting of test results. CloudLIMS can be easily configured to support new test methods, assays, and reporting requirements, including those of FDA and CDC, avoiding time-consuming customization. The preconfiguration helps minimize onboarding time and enables laboratories to go-live within just a couple of days. CloudLIMS can be accessed anytime, anywhere, is easy to deploy, and enables COVID-19 laboratories to quickly automate without the need to invest in IT infrastructure or personnel.
CloudLIMS customers have realized benefits in the following ways:
Certificate of Analysis
Clinical diagnostic testing laboratories receive hundreds of COVID-19 specimens on a day-to-day basis. One of the most common and reliable tests used for testing COVID-19 specimens is RT-PCR, a real-time reverse transcription polymerase chain reaction (RT-PCR) test for the qualitative detection of RNA of SARS-CoV-2. DNA sequencing is done for the confirmation of test results if required. Manual transfer of analytical data of thousands of specimens from RT-PCR instruments and other analytical instruments to a LIMS is error-prone and reduces laboratory efficiency. For minimizing the test turnaround time, it is important to automate the data transfer process. CloudLIMS can be seamlessly integrated with analytical instruments for bi-directional data transfer, thereby reducing turnaround time and eliminating chances of transcription errors.
CloudLIMS supports integration with analytical instruments and software through the following methods:
CloudLIMS is preconfigured to seamlessly integrate with COVID-19 testing instruments, such as RT-PCR, NGS instruments, for bi-directional data transfer. CloudLIMS’ REST Application Programming Interface (API) enables developers to read and write data from/to an analytical instrument, ensuring data integrity and minimizing turnaround time.
CloudLIMS' Rest API is preconfigured to support integration with third-party software such as EMR, EHR, LIS, Patient Registries, etc. It can be integrated with the electronic reporting system of CDC/CSTE, FEMA, and other e-reporting tools, thereby automating reporting of test results. Furthermore, it can be integrated with medical or clinical billing software to effectively manage revenue cycles and minimize billing errors, enhancing customer experience.
A major challenge concerning the COVID-19 virus is its detection...
A major challenge in the control of COVID-19 is its detection...
It is no secret the breathtaking advance of the COVID-19 virus has placed pressure...